EUVIMED · CrossrefZeitschrift
CA: A Cancer Journal for Clinicians
ISSN 0007-9235 · Wiley
Neueste Artikel
Issue Information
Screening for prostate cancer
Continuous‐duration maintenance therapy offers no overall survival gain in patients with newly diagnosed multiple myeloma
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer
Colorectal cancer screening: An update to the American Cancer Society guideline, 2026
Colorectal cancer statistics, 2026
Global cancer statistics for children: Two decades of change and projections to 2050
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
Cancer statistics, 2026
American Cancer Society’s Report on the Status of Cancer Disparities in the United States, 2025
Human papillomavirus self‐collection: The long road from scientific evaluation to implementation in screening programs
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer
Cancer statistics, 2026: Charting a course for a national cancer research agenda
Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs
Correction to “Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers”
Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians
The contemporary management of prostate cancer
Prostate cancer statistics, 2025
Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Cancer in rural America: Improving access to clinical trials and quality of oncologic care
Cancer treatment and survivorship statistics, 2025
Cancer treatment and survivorship statistics, 2025: An urgent call to optimize health after cancer
Novel clinical trial designs emerging from the molecular reclassification of cancer
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
Jahrgänge
2026 · 522025 · 572024 · 512023 · 502022 · 492021 · 492020 · 592019 · 482018 · 572017 · 552016 · 562015 · 472014 · 472013 · 412012 · 402011 · 412010 · 392009 · 522008 · 382007 · 442006 · 442005 · 492004 · 472003 · 502002 · 542001 · 562000 · 331999 · 331998 · 341997 · 301996 · 291995 · 311994 · 281993 · 381992 · 291991 · 411990 · 421989 · 751988 · 561987 · 53
EUVIMED